Source: Eur Respir J, 49 (6) 1700485; 10.1183/13993003.00485-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Helgo Magnussen, Michael Arzt, Stefan Andreas, Tanja Plate, Anna Ribera, Beatriz Seoane, Henrik Watz, Anne-Marie Kirsten. Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study. Eur Respir J, 49 (6) 1700485; 10.1183/13993003.00485-2017

Member's Comments

No comment yet.

Related content which might interest you: The effect of aclidinium bromide 400 µg on sleep quality in COPD: A pilot study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 ACCORD COPD I: Twice-daily aclidinium bromide improves quality of life and dyspnea in COPD patients Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Indacaterol once-daily improves health-related quality of life (HRQOL) in COPD patients: a 52-week study Source: Annual Congress 2009 - New bronchodilators Year: 2009 Improvement in COPD symptoms with aclidinium bromide vs placebo and tiotropium: A phase IIIb study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 ACCORD COPD I: Improvements in nighttime symptoms and rescue medication use in COPD with twice-daily aclidinium bromide Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Combined tiotropium + olodaterol influences physical functioning in COPD: Results of an open-label observational study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Effect of treatment with tiotropium bromide 18 mcg on asthma control and asthma-related quality of life in patients with asthma-COPD overlap syndrome. Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study Source: Eur Respir J 2014; 43: 1599-1609 Year: 2014 Once-daily QVA149 demonstrates superior improvements in patient-reported dyspnea compared to tiotropium in patients with moderate-to-severe COPD: The BLAZE study Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Managing chronic obstructive pulmonary disease (COPD) in real life: the role of adding tiotropium bromide in relation to quality of life and costs Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Impact of cough on quality of sleep and effect of anti-tussive treatment in children: An observational study Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011 Improvement in HRQoL of COPD patients after 9 months‘ treatment with tiotropium bromide: use of a new scale for daily medical practice Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Influence of tiotropium bromide (TB) on the severity of clinical, functional symptoms and health-related quality of life (HRQL) in COPD patients (pts) Source: Annual Congress 2011 - COPD management Year: 2011 Pooled analysis of twice-daily aclidinium bromide in COPD patients: Dyspnea and health status in the ACCORD-COPD I and ATTAIN trials Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study Source: Eur Respir J 2002; 20: 1138-1146 Year: 2002 The role of tiotropium bromide in physical training for patients with COPD Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007 Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002 Aclidinium bromide improves resting lung function in patients with moderate to severe COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010